Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma PatientsJacalyn Rosenblatt, David Avigan, Viki Held et al.|Clinical Cancer Research|2013Cited by 209
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and May Lead to Eradication of Measureable DiseaseJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Blood|2015Cited by 12
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell TransplantationJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Transplantation and Cellular Therapy|2013Cited by 7
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced RemissionJacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Transplantation and Cellular Therapy|2012Cited by 2
Data from Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma PatientsJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Unknown|2023Cited by 0